Long-term survival in multiple myeloma: A Finnish Leukaemia Group study

British Journal of Haematology

Volumn 105, Issue 4, 1999, Pages 942-947

  Oivanen, T ^a   Ala Harja, K ^b   Almqvist, A ^b   Apajalahti, J ^b   Elonen, E ^b   Hallman, H ^b   Hanninen A ^b   Ilvonen, M ^b   Isomaa, B ^b   Jouppila, J ^b   Jarvenpaa E ^b   Jarventic G ^b   Kilpi, H ^b   Koistinen, P ^b   Koistinen, S ^b   Koivisto, A M ^b   Koivunen, E ^b   Korpi, E ^b   Katka K ^b   Kaariainen M ^b   Lahtinen, R ^b   Laitinen, A ^b   Lehtinen, M ^b   Makela H ^b   Nylanden P ^b   Nyman, D ^b   Palva, I ^b   Pelliniemi, T T ^b   Pulli, T ^b   Rajamaki A ^b   Rauhala, A ^b   Remes, K ^b   Rosengard S ^b   Ruutu, T ^b   Soininen, K ^b   Tiilikainen, J ^b   Timonen, T ^b   Waris, E ^b   Vilpo, J ^b   Volin, L ^b   more..

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b NONE

Author keywords

Long term survival; Myeloma; Prognosis; Staging

Indexed keywords

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FINLAND; HEMATOCRIT; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME; THROMBOCYTE COUNT;

ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTICENTER STUDIES; MULTIPLE MYELOMA; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0033060289     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01462.x     Document Type: Article

References (18)

1. Alexanian, R. (1985) Ten-years survival in multiple myeloma. Archives of Internal Medicine, 145, 2073-2074.
2. Buckman, R., Cuzick, J. & Galton, D.A.G. (1982) Long-term survival in myelomatosis: a report to the MRC Working Party on Leukaemia in Adults. British Journal of Haematology, 52, 589-599.
3. Chronic Leukemia-Myeloma Task Force (1973) Proposed guidelines for clinical studies. Cancer Chemotherapy Reports, 4, 145-158.
4. Cox, D.R. & Oakes, D. (1984) Analysis of Survival Data. Chapman and Hall, London.
5. Durie, B.G. & Salmon, S.E. (1975) A clinical staging system for multiple myeloma: correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
6. Finnish Cancer Registry (1997) Cancer Incidence in Finland 1995. Cancer Society of Finland, Helsinki.
7. Finnish Leukaemia Group (1985) Aggressive combination chemotherapy in multiple myeloma: a multicentre trial. Scandinavian Journal of Haematology, 35, 205-209.
8. Finnish Leukaemia Group (1987) Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone: a randomised multicentre trial. European Journal of Haematology, 38, 50-54.
9. Finnish Leukaemia Group (1989) Treatment of multiple myeloma in old patients. European Journal of Haematology, 43, 328-331.
10. Finnish Leukaemia Group (1993) Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. European Journal of Haematology, 51, 98-101.
11. Karjalainen, S. & Palva, I. (1989) Do protocols improve end results? A study of survival of patients with multiple myeloma in Finland. British Journal of Medicine, 229, 1069-1072.
12. Kyle, R. (1983) Long-term survival in multiple myeloma. New England Journal of Medicine, 308, 314-316.
13. Lee, J.B. & Myers, J. (1983) Long-term survival in multiple myeloma. New England Journal of Medicine, 309, 243-244.
14. Myeloma Trialists' Collaborative Group (1998) Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomised trials. Journal of Clinical Oncology, 16, 3832-3842.
15. Oivanen, T. (1996) Plateau phase in multiple myeloma: an analysis of long-term follow-up of 432 patients. British Journal of Haematology, 92, 834-839.
16. Oivanen, T. (1997) Conventional chemotherapy for multiple myeloma: an overview of 432 patients treated in multicentre trials. Doctoral thesis, Acta Universitatis Tamperensis.
17. Oken, M., Harrington, D., Abramson, N., Kyle, R., Knospe, W. & Glick, J. (1997) Comparison of melphalan and prednisone with vincristina, carmustine, melphalan, cyclophosphamide and predisone in the treatment of multiple myeloma. Results of Eastern Cooperative Oncology Group study E2479. Cancer, 79, 1561-1567.
18. Tsuchiya, J., Murakami, H., Kanoh, T., Kosaka, M., Sezaki, T., Mikuni, C., Kawato, M., Takagi, T., Togawa, A., Isobe, T., Suzuki, K., Imamura, Y., Takatsuki, K., Shirakawa, S., Takahashi, I., Nagai, K., Hirai, H. & Hirano, M. (1994) 10-year survival and prognostic factors in multiple myeloma. British Journal of Haematology, 87, 832-834.